Literatures

Primary Site >> Pancreatic Cancer

Gene >> KDR

1.
Journal:	Int J Cancer. 2000 Jan 1;85(1):27-34.
Title:	Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
Author:	Itakura, J\|Ishiwata, T\|Shen, B\|Kornmann, M\|Korc, M
PMID:	10585578

2.
Journal:	Gastroenterology. 2000 Nov;119(5):1358-72.
Title:	De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
Author:	von Marschall, Z\|Cramer, T\|Hocker, M\|Burde, R\|Plath, T\|Schirner, M\|Heidenreich, R\|Breier, G\|Riecken, E O\|Wiedenmann, B\|Rosewicz, S
PMID:	11054395

3.
Journal:	Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4605-10. Epub 2001 Mar 27.
Title:	Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
Author:	Kuo, C J\|Farnebo, F\|Yu, E Y\|Christofferson, R\|Swearingen, R A\|Carter, R\|von Recum, H A\|Yuan, J\|Kamihara, J\|Flynn, E\|D'Amato, R\|Folkman, J\|Mulligan, R C
PMID:	11274374

4.
Journal:	Histol Histopathol. 2001 Apr;16(2):359-75.
Title:	Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
Author:	Dunk, C\|Ahmed, A
PMID:	11332691

5.
Journal:	Surgery. 2002 Nov;132(5):857-65.
Title:	Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
Author:	Tseng, Jennifer F\|Farnebo, Filip A\|Kisker, Oliver\|Becker, Christian M\|Kuo, Calvin J\|Folkman, Judah\|Mulligan, Richard C
PMID:	12464871

6.
Journal:	Cancer Res. 2003 Sep 15;63(18):5978-91.
Title:	CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Author:	Ruggeri, Bruce\|Singh, Jasbir\|Gingrich, Diane\|Angeles, Thelma\|Albom, Mark\|Yang, Shi\|Chang, Hong\|Robinson, Candy\|Hunter, Kathryn\|Dobrzanski, Pawel\|Jones-Bolin, Susan\|Pritchard, Sonya\|Aimone, Lisa\|Klein-Szanto, Andres\|Herbert, Jean-Marc\|Bono, Francoise\|Schae
PMID:	14522925

7.
Journal:	Cancer. 2004 Nov 15;101(10):2341-50.
Title:	Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Author:	Li, Min\|Yang, Hui\|Chai, Hong\|Fisher, William E\|Wang, Xiaoping\|Brunicardi, F Charles\|Yao, Qizhi\|Chen, Changyi
PMID:	15476280

8.
Journal:	Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):678-89.
Title:	Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
Author:	Davis, Darren W\|Takamori, Ryan\|Raut, Chandrajit P\|Xiong, Henry Q\|Herbst, Roy S\|Stadler, Walter M\|Heymach, John V\|Demetri, George D\|Rashid, Asif\|Shen, Yu\|Wen, Sijin\|Abbruzzese, James L\|McConkey, David J
PMID:	15701856

9.
Journal:	Curr Cancer Drug Targets. 2005 May;5(3):171-93.
Title:	Molecularly targeted therapy for gastrointestinal cancer.
Author:	Wiedmann, Marcus W\|Caca, Karel
PMID:	15892618

10.
Journal:	Neoplasia. 2005 Jul;7(7):696-704.
Title:	Induction of apoptosis in tumor-associated endothelial cells and therapy of orthotopic human pancreatic carcinoma in nude mice.
Author:	Yokoi, Kenji\|Kim, Sun-Jin\|Thaker, Premal\|Yazici, Sertac\|Nam, Do-Hyun\|He, Junqin\|Sasaki, Takamitsu\|Chiao, Paul J\|Sclabas, Guido M\|Abbruzzese, James L\|Hamilton, Stanley R\|Fidler, Isaiah J
PMID:	16026649

11.
Journal:	Cancer Res. 2005 Nov 15;65(22):10371-80.
Title:	Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.
Author:	Yokoi, Kenji\|Sasaki, Takamitsu\|Bucana, Corazon D\|Fan, Dominic\|Baker, Cheryl H\|Kitadai, Yasuhiko\|Kuwai, Toshio\|Abbruzzese, James L\|Fidler, Isaiah J
PMID:	16288027

12.
Journal:	Cancer. 2006 Apr 15;106(8):1677-84.
Title:	Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Author:	Chung, Gina G\|Yoon, Harry H\|Zerkowski, Maciej P\|Ghosh, Sriparna\|Thomas, Laurie\|Harigopal, Malini\|Charette, Lori A\|Salem, Ronald R\|Camp, Robert L\|Rimm, David L\|Burtness, Barbara A
PMID:	16532435

13.
Journal:	Drug Resist Updat. 2006 Feb-Apr;9(1-2):1-18. Epub 2006 Apr 18.
Title:	Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
Author:	Kleespies, Axel\|Jauch, Karl-Walter\|Bruns, Christiane J
PMID:	16621676

14.
Journal:	Clin Cancer Res. 2006 Apr 15;12(8):2628-33.
Title:	Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
Author:	Camp, E Ramsay\|Yang, Anthony\|Liu, Wenbiao\|Fan, Fan\|Somcio, Ray\|Hicklin, Daniel J\|Ellis, Lee M
PMID:	16638876

15.
Journal:	Biochem Biophys Res Commun. 2006 Jun 23;345(1):292-301. Epub 2006 May 2.
Title:	Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins.
Author:	Higgins, Kelly J\|Abdelrahim, Maen\|Liu, Shengxi\|Yoon, Kyungsil\|Safe, Stephen
PMID:	16678129

16.
Journal:	Ann Surg Oncol. 2006 Aug;13(8):1145-55.
Title:	Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts.
Author:	Holloway, Shane E\|Beck, Adam W\|Shivakumar, Latha\|Shih, Jessica\|Fleming, Jason B\|Brekken, Rolf A
PMID:	16791450

17.
Journal:	Br J Cancer. 2007 Oct 22;97(8):1116-23. Epub 2007 Sep 25.
Title:	Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines.
Author:	Hurt, E M\|Thomas, S B\|Peng, B\|Farrar, W L
PMID:	17895890

18.
Journal:	Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):873-9.
Title:	SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation.
Author:	Cuneo, Kyle C\|Geng, Ling\|Fu, Allie\|Orton, Darren\|Hallahan, Dennis E\|Chakravarthy, Anuradha Bapsi
PMID:	18514780

19.
Journal:	Cancer Res. 2008 Jun 1;68(11):4340-6.
Title:	Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.
Author:	Dineen, Sean P\|Lynn, Kristi D\|Holloway, Shane E\|Miller, Andrew F\|Sullivan, James P\|Shames, David S\|Beck, Adam W\|Barnett, Carlton C\|Fleming, Jason B\|Brekken, Rolf A
PMID:	18519694

20.
Journal:	Mol Cancer Ther. 2008 Nov;7(11):3509-18.
Title:	Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes.
Author:	Lang, Sven A\|Schachtschneider, Philipp\|Moser, Christian\|Mori, Akira\|Hackl, Christina\|Gaumann, Andreas\|Batt, David\|Schlitt, Hans J\|Geissler, Edward K\|Stoeltzing, Oliver
PMID:	19001434

21.
Journal:	Clin Cancer Res. 2008 Nov 15;14(22):7272-83.
Title:	Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Author:	Hu-Lowe, Dana D\|Zou, Helen Y\|Grazzini, Maren L\|Hallin, Max E\|Wickman, Grant R\|Amundson, Karin\|Chen, Jeffrey H\|Rewolinski, David A\|Yamazaki, Shinji\|Wu, Ellen Y\|McTigue, Michele A\|Murray, Brion W\|Kania, Robert S\|O'Connor, Patrick\|Shalinsky, David R\|Bender,
PMID:	19010843

22.
Journal:	BMC Cancer. 2008 Nov 27;8:352.
Title:	The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Author:	Dineen, Sean P\|Sullivan, Laura A\|Beck, Adam W\|Miller, Andrew F\|Carbon, Juliet G\|Mamluk, Roni\|Wong, Henry\|Brekken, Rolf A
PMID:	19038046

23.
Journal:	Transl Oncol. 2008 Dec;1(4):195-201.
Title:	Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells.
Author:	Spalding, Aaron C\|Zeitlin, Benjamin D\|Wilder-Romans, Kari\|Davis, Mary E\|Nor, Jacques E\|Lawrence, Theodore S\|Ben-Josef, Edgar
PMID:	19043530

24.
Journal:	Gan To Kagaku Ryoho. 2008 Nov;35(12):2271-3.
Title:	[A phase I study of combination-therapy with gemcitabine and epitope peptides derived from human vascular endothelial growth factor receptor for unresectable or recurrent pancreas cancer].
Author:	Kim, Dal Ho\|Shiozawa, Shunichi\|Usui, Takebumi\|Yoshimatsu, Kazuhiko\|Otani, Taisuke\|Tsunoda, Takuya\|Nakamura, Yusuke\|Ogawa, Kenji
PMID:	19106593

25.
Journal:	Biologics. 2008 Dec;2(4):707-15.
Title:	Small molecule tyrosine kinase inhibitors in pancreatic cancer.
Author:	Gupta, Sachin\|El-Rayes, Bassel F
PMID:	19707451

26.
Journal:	J Cell Physiol. 2009 Apr;219(1):209-18.
Title:	The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Author:	Zou, Gang-Ming\|Karikari, Collins\|Kabe, Yasuaki\|Handa, Hiroshi\|Anders, Robert A\|Maitra, Anirban
PMID:	19097035

27.
Journal:	Gan To Kagaku Ryoho. 2009 Feb;36(2):187-92.
Title:	[Treatments of epithelial ovarian cancer by histologic subtype].
Author:	Sugiyama, Toru\|Kumagai, Seisuke\|Hatayama, Shinya
PMID:	19223734

28.
Journal:	Anticancer Res. 2009 Jun;29(6):1999-2007.
Title:	Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
Author:	Tonra, James R\|Corcoran, Erik\|Deevi, Dhanvanthri S\|Steiner, Philipp\|Kearney, Jessica\|Li, Huiling\|Ludwig, Dale L\|Zhu, Zhenping\|Witte, Larry\|Surguladze, David\|Hicklin, Daniel J
PMID:	19528458

29.
Journal:	Mol Cancer Ther. 2009 Jul;8(7):1761-71.
Title:	Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts.
Author:	Roland, Christina L\|Dineen, Sean P\|Lynn, Kristi D\|Sullivan, Laura A\|Dellinger, Michael T\|Sadegh, Leila\|Sullivan, James P\|Shames, David S\|Brekken, Rolf A
PMID:	19567820

30.
Journal:	Nat Rev Clin Oncol. 2009 Oct;6(10):569-79.
Title:	An overview of small-molecule inhibitors of VEGFR signaling.
Author:	Ivy, S Percy\|Wick, Jeannette Y\|Kaufman, Bennett M
PMID:	19736552

31.
Journal:	Cancer Sci. 2010 Feb;101(2):433-9.
Title:	Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer.
Author:	Miyazawa, Motoki\|Ohsawa, Ryuji\|Tsunoda, Takuya\|Hirono, Seiko\|Kawai, Manabu\|Tani, Masaji\|Nakamura, Yusuke\|Yamaue, Hiroki
PMID:	19930156

32.
Journal:	Cancer Sci. 2010 Jun;101(6):1529-35.
Title:	Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer.
Author:	Doi, Yosuke\|Yashiro, Masakazu\|Yamada, Nobuya\|Amano, Ryosuke\|Ohira, Go\|Komoto, Masahiro\|Noda, Satoru\|Kashiwagi, Shinichiro\|Kato, Yukihiro\|Fuyuhiro, Yuhiko\|Hirakawa, Kosei
PMID:	20367641

33.
Journal:	Mol Imaging Biol. 2010 Dec;12(6):570-5.
Title:	Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model.
Author:	Angst, Eliane\|Chen, Monica\|Mojadidi, Michelle\|Hines, O Joe\|Reber, Howard A\|Eibl, Guido
PMID:	20376570

34.
Journal:	Mol Pharmacol. 2010 Aug;78(2):226-36.
Title:	Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
Author:	Jutooru, Indira\|Chadalapaka, Gayathri\|Abdelrahim, Maen\|Basha, Md Riyaz\|Samudio, Ismael\|Konopleva, Marina\|Andreeff, Michael\|Safe, Stephen
PMID:	20488920

35.
Journal:	Chemotherapy. 2010;56(4):303-12.
Title:	Synergistic cytotoxicity and molecular interaction on drug targets of sorafenib and gemcitabine in human pancreas cancer cells.
Author:	Ricciardi, Simona\|Mey, Valentina\|Nannizzi, Sara\|Pasqualetti, Giuseppe\|Crea, Francesco\|Del Tacca, Mario\|Danesi, Romano
PMID:	20714148

36.
Journal:	Neoplasia. 2010 Oct;12(10):797-806.
Title:	Specific targeting of tumor endothelial cells by a shiga-like toxin-vascular endothelial growth factor fusion protein as a novel treatment strategy for pancreatic cancer.
Author:	Hotz, Birgit\|Backer, Marina V\|Backer, Joseph M\|Buhr, Heinz-J\|Hotz, Hubert G
PMID:	20927318

37.
Journal:	Cancer Res. 2010 Nov 1;70(21):8812-21.
Title:	Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.
Author:	Qin, Jun\|Chen, Xinpu\|Yu-Lee, Li-Yuan\|Tsai, Ming-Jer\|Tsai, Sophia Y
PMID:	20978203

38.
Journal:	Toxins (Basel). 2010 Sep;2(9):2242-57.
Title:	SLT-VEGF reduces lung metastases, decreases tumor recurrence, and improves survival in an orthotopic melanoma model.
Author:	Ackerman, Rachel\|Backer, Joseph M\|Backer, Marina\|Skariah, Sini\|Hamby, Carl V
PMID:	22069683

39.
Journal:	Radiology. 2011 Mar;258(3):804-11.
Title:	Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
Author:	Deshpande, Nirupama\|Ren, Ying\|Foygel, Kira\|Rosenberg, Jarrett\|Willmann, Jurgen K
PMID:	21339349

40.
Journal:	Neoplasia. 2011 Mar;13(3):217-29.
Title:	Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
Author:	Canu, Bastianina\|Fioravanti, Anna\|Orlandi, Paola\|Di Desidero, Teresa\|Ali, Greta\|Fontanini, Gabriella\|Di Paolo, Antonello\|Del Tacca, Mario\|Danesi, Romano\|Bocci, Guido
PMID:	21390185

41.
Journal:	Clin Cancer Res. 2011 Aug 15;17(16):5299-310.
Title:	Brivanib, a dual FGF/VEGF inhibitor, is active both first and second line against mouse pancreatic neuroendocrine tumors developing adaptive/evasive resistance to VEGF inhibition.
Author:	Allen, Elizabeth\|Walters, Ian B\|Hanahan, Douglas
PMID:	21622725

42.
Journal:	Mol Cancer Ther. 2011 Nov;10(11):2157-67.
Title:	Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
Author:	Taeger, Johannes\|Moser, Christian\|Hellerbrand, Claus\|Mycielska, Maria E\|Glockzin, Gabriel\|Schlitt, Hans J\|Geissler, Edward K\|Stoeltzing, Oliver\|Lang, Sven A
PMID:	21885862

43.
Journal:	PLoS One. 2011;6(10):e25799.
Title:	Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-alpha/VEGF/Rho-GTPases: pivotal role of STAT-3.
Author:	Boreddy, Srinivas Reddy\|Sahu, Ravi P\|Srivastava, Sanjay K
PMID:	22016776

44.
Journal:	Gan To Kagaku Ryoho. 2011 Nov;38(12):1903-5.
Title:	[The development of a novel cancer vaccine using Peptide vaccine for patients with advanced pancreatic cancer].
Author:	Miyazawa, Motoki\|Yamaue, Hiroki
PMID:	22202233

45.
Journal:	Invest New Drugs. 2012 Feb;30(1):382-6.
Title:	Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.
Author:	Kindler, Hedy Lee\|Wroblewski, Kristen\|Wallace, James A\|Hall, Michael J\|Locker, Gershon\|Nattam, Sreenivasa\|Agamah, Edem\|Stadler, Walter M\|Vokes, Everett E
PMID:	20803052

46.
Journal:	Ann Surg Oncol. 2012 Jul;19 Suppl 3:S464-74.
Title:	High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
Author:	Chen, Hai-Tao\|Cai, Quan-Cai\|Zheng, Jian-Ming\|Man, Xiao-Hua\|Jiang, Hui\|Song, Bin\|Jin, Gang\|Zhu, Wei\|Li, Zhao-Shen
PMID:	21822553

47.
Journal:	Ann Surg Oncol. 2012 Aug;19(8):2733-43.
Title:	VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
Author:	Doi, Yosuke\|Yashiro, Masakazu\|Yamada, Nobuya\|Amano, Ryosuke\|Noda, Satoru\|Hirakawa, Kosei
PMID:	22207048

48.
Journal:	Clin Cancer Res. 2012 May 15;18(10):2838-49.
Title:	Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Author:	Speisky, Daniela\|Duces, Aurelie\|Bieche, Ivan\|Rebours, Vinciane\|Hammel, Pascal\|Sauvanet, Alain\|Richard, Stephane\|Bedossa, Pierre\|Vidaud, Michel\|Murat, Arnaud\|Niccoli, Patricia\|Scoazec, Jean-Yves\|Ruszniewski, Philippe\|Couvelard, Anne
PMID:	22461457

49.
Journal:	Eur J Clin Invest. 2012 Oct;42(10):1061-7.
Title:	Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Author:	Nguyen, Jennifer P\|Frost, Chelsea D\|Lane, Meghan L\|Skelton Iv, William P\|Skelton, Michelle\|Vesely, David L
PMID:	22703300

50.
Journal:	PLoS One. 2012;7(8):e42146.
Title:	Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
Author:	Lin, Sheng-Zhang\|Wei, Wei-Tian\|Chen, Hui\|Chen, Kang-Jie\|Tong, Hong-Fei\|Wang, Zhao-Hong\|Ni, Zhong-Lin\|Liu, Hai-Bin\|Guo, Hong-Chun\|Liu, Dian-Lei
PMID:	22876305

51.
Journal:	BMC Cancer. 2012 Aug 20;12:361.
Title:	Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
Author:	Niethammer, Andreas G\|Lubenau, Heinz\|Mikus, Gerd\|Knebel, Philipp\|Hohmann, Nicolas\|Leowardi, Christine\|Beckhove, Philipp\|Akhisaroglu, Mustafa\|Ge, Yingzi\|Springer, Marco\|Grenacher, Lars\|Buchler, Markus W\|Koch, Moritz\|Weitz, Jurgen\|Haefeli, Walter E\|Schmitz-
PMID:	22906006

52.
Journal:	J Pharmacol Exp Ther. 2012 Dec;343(3):617-27.
Title:	Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase families.
Author:	Glaser, Keith B\|Li, Junling\|Marcotte, Patrick A\|Magoc, Terrance J\|Guo, Jun\|Reuter, David R\|Tapang, Paul\|Wei, Ru-Qi\|Pease, Lori J\|Bui, Mai H\|Chen, Zehan\|Frey, Robin R\|Johnson, Eric F\|Osterling, Donald J\|Olson, Amanda M\|Bouska, Jennifer J\|Luo, Yanping\|Curti
PMID:	22935731

53.
Journal:	Pancreas. 2013 Apr;42(3):411-21.
Title:	Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
Author:	Gilbert, Judith A\|Adhikari, Laura J\|Lloyd, Ricardo V\|Halfdanarson, Thorvardur R\|Muders, Michael H\|Ames, Matthew M
PMID:	23211371

54.
Journal:	Ann Oncol. 2013 May;24(5):1282-90.
Title:	VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma.
Author:	Uzunoglu, F G\|Kolbe, J\|Wikman, H\|Gungor, C\|Bohn, B A\|Nentwich, M F\|Reeh, M\|Konig, A M\|Bockhorn, M\|Kutup, A\|Mann, O\|Izbicki, J R\|Vashist, Y K
PMID:	23293110

55.
Journal:	Br J Cancer. 2013 Mar 19;108(5):1052-60.
Title:	Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.
Author:	Miles, D W\|de Haas, S L\|Dirix, L Y\|Romieu, G\|Chan, A\|Pivot, X\|Tomczak, P\|Provencher, L\|Cortes, J\|Delmar, P R\|Scherer, S J
PMID:	23422754

56.
Journal:	J Cell Mol Med. 2013 Jun;17(6):792-9.
Title:	An intensified systemic trafficking of bone marrow-derived stem/progenitor cells in patients with pancreatic cancer.
Author:	Starzynska, Teresa\|Dabkowski, Krzysztof\|Blogowski, Wojciech\|Zuba-Surma, Ewa\|Budkowska, Marta\|Salata, Daria\|Dolegowska, Barbara\|Marlicz, Wojciech\|Lubikowski, Jerzy\|Ratajczak, Mariusz Z
PMID:	23672538

57.
Journal:	Pancreatology. 2013 Jul-Aug;13(4):415-22.
Title:	Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysis.
Author:	Tian, Wei\|Ding, Wenping\|Kim, Sungkyoung\|Xu, Xiaoxing\|Pan, Minggui\|Chen, Siyu
PMID:	23890141

58.
Journal:	Cell Signal. 2013 Dec;25(12):2587-603.
Title:	A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Author:	Gilmour, Alanna M\|Abdulkhalek, Samar\|Cheng, Timothy S W\|Alghamdi, Farah\|Jayanth, Preethi\|O'Shea, Leah K\|Geen, Olivia\|Arvizu, Luis A\|Szewczuk, Myron R
PMID:	23993964

59.
Journal:	PLoS One. 2013 Sep 4;8(9):e72480.
Title:	Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody.
Author:	Hernandez, Jose Luis\|Padilla, Laura\|Dakhel, Sheila\|Coll, Toni\|Hervas, Rosa\|Adan, Jaume\|Masa, Marc\|Mitjans, Francesc\|Martinez, Josep Maria\|Coma, Silvia\|Rodriguez, Laura\|Noe, Veronique\|Ciudad, Carlos J\|Blasco, Francesc\|Messeguer, Ramon
PMID:	24023743

60.
Journal:	PLoS One. 2013 Sep 9;8(9):e73940.
Title:	DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Author:	Sureban, Sripathi M\|May, Randal\|Qu, Dongfeng\|Weygant, Nathaniel\|Chandrakesan, Parthasarathy\|Ali, Naushad\|Lightfoot, Stan A\|Pantazis, Panayotis\|Rao, Chinthalapally V\|Postier, Russell G\|Houchen, Courtney W
PMID:	24040120

61.
Journal:	Oncoimmunology. 2013 Nov 1;2(11):e27010.
Title:	Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients.
Author:	Okuyama, Ryuji\|Aruga, Atsushi\|Hatori, Takashi\|Takeda, Kazuyoshi\|Yamamoto, Masakazu
PMID:	24498547

62.
Journal:	Br J Cancer. 2014 Jan 21;110(2):320-9.
Title:	Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.
Author:	Zhang, H\|Hylander, B L\|LeVea, C\|Repasky, E A\|Straubinger, R M\|Adjei, A A\|Ma, W W
PMID:	24327018

63.
Journal:	PLoS One. 2014 Jan 9;9(1):e82209.
Title:	A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Espanol Multidisciplinario en Cancer Digestivo (GEMCAD) study.
Author:	Aparicio, Jorge\|Garcia-Mora, Carmen\|Martin, Marta\|Petriz, Ma Lourdes\|Feliu, Jaime\|Sanchez-Santos, Ma Elena\|Ayuso, Juan Ramon\|Fuster, David\|Conill, Carlos\|Maurel, Joan
PMID:	24416138

64.
Journal:	Cancer Immunol Immunother. 2014 May;63(5):479-89.
Title:	P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.
Author:	Terashima, Takeshi\|Mizukoshi, Eishiro\|Arai, Kuniaki\|Yamashita, Tatsuya\|Yoshida, Mariko\|Ota, Hajime\|Onishi, Ichiro\|Kayahara, Masato\|Ohtsubo, Koushiro\|Kagaya, Takashi\|Honda, Masao\|Kaneko, Shuichi
PMID:	24633336

65.
Journal:	PLoS One. 2014 Apr 2;9(4):e92161.
Title:	Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
Author:	Huang, Minzhao\|Tang, Su-Ni\|Upadhyay, Ghanshyam\|Marsh, Justin L\|Jackman, Christopher P\|Shankar, Sharmila\|Srivastava, Rakesh K
PMID:	24694877

66.
Journal:	Cancer Lett. 2014 Aug 28;351(1):151-61.
Title:	XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.
Author:	Sureban, Sripathi M\|May, Randal\|Weygant, Nathaniel\|Qu, Dongfeng\|Chandrakesan, Parthasarathy\|Bannerman-Menson, Eddie\|Ali, Naushad\|Pantazis, Panayotis\|Westphalen, Christoph B\|Wang, Timothy C\|Houchen, Courtney W
PMID:	24880079

67.
Journal:	Cancer Sci. 2014 Sep;105(9):1116-23.
Title:	Expression of platelet-derived growth factor receptor beta is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis.
Author:	Miyazaki, Hideki\|Yoshimatsu, Yasuhiro\|Akatsu, Yuichi\|Mishima, Koichi\|Fukayama, Masashi\|Watabe, Tetsuro\|Miyazono, Kohei
PMID:	24981766

68.
Journal:	Cell Rep. 2014 Aug 7;8(3):696-706.
Title:	Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade.
Author:	Rigamonti, Nicolo\|Kadioglu, Ece\|Keklikoglou, Ioanna\|Wyser Rmili, Celine\|Leow, Ching Ching\|De Palma, Michele
PMID:	25088418

69.
Journal:	Pathol Res Pract. 2014 Dec;210(12):901-8.
Title:	Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas.
Author:	Liszka, Lukasz\|Pajak, Jacek\|Golka, Dariusz
PMID:	25155377

70.
Journal:	World J Gastroenterol. 2014 Oct 7;20(37):13343-68.
Title:	Gene therapy in pancreatic cancer.
Author:	Liu, Si-Xue\|Xia, Zhong-Sheng\|Zhong, Ying-Qiang
PMID:	25309069

71.
Journal:	Radiology. 2015 Mar;274(3):790-9.
Title:	Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
Author:	Pysz, Marybeth A\|Machtaler, Steven B\|Seeley, E Scott\|Lee, John J\|Brentnall, Teresa A\|Rosenberg, Jarrett\|Tranquart, Francois\|Willmann, Jurgen K
PMID:	25322341

72.
Journal:	Virchows Arch. 2015 Feb;466(2):237-41.
Title:	Basaloid carcinoma of the pancreas--clinicopathological presentation and oncogenetic snapshot of a rare entity.
Author:	Szasz, A Marcell\|Szirtes, Ildiko\|Tihanyi, Balazs\|Barkaszi, Bernadett\|Baranyai, Zsolt\|Tihanyi, Tibor\|Harsanyi, Laszlo\|Timar, Jozsef\|Kulka, Janina
PMID:	25432630

73.
Journal:	Mol Cancer Ther. 2015 Feb;14(2):407-18.
Title:	A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
Author:	Pan, Youli\|Zheng, Mingwu\|Zhong, Lei\|Yang, Jiao\|Zhou, Shu\|Qin, Ya\|Xiang, Rong\|Chen, Yuzong\|Yang, Sheng-Yong
PMID:	25519702

74.
Journal:	Oncotarget. 2015 Jun 20;6(17):14940-52.
Title:	Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
Author:	Chen, Hsiu-Mei\|Tsai, Chia-Hua\|Hung, Wen-Chun
PMID:	25909285

75.
Journal:	Oncotarget. 2015 Jul 20;6(20):17981-8000.
Title:	Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Author:	Jeanne, Albin\|Sick, Emilie\|Devy, Jerome\|Floquet, Nicolas\|Belloy, Nicolas\|Theret, Louis\|Boulagnon-Rombi, Camille\|Diebold, Marie-Daniele\|Dauchez, Manuel\|Martiny, Laurent\|Schneider, Christophe\|Dedieu, Stephane
PMID:	26046793

76.
Journal:	Cancer Genet. 2015 Jul-Aug;208(7-8):374-81.
Title:	Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Author:	Boora, Ganesh K\|Kanwar, Rahul\|Kulkarni, Amit A\|Pleticha, Josef\|Ames, Matthew\|Schroth, Gary\|Beutler, Andreas S\|Banck, Michaela S
PMID:	26087898

77.
Journal:	Oncoimmunology. 2015 Mar 16;4(4):e1001217.
Title:	Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial.
Author:	Schmitz-Winnenthal, Friedrich H\|Hohmann, Nicolas\|Niethammer, Andreas G\|Friedrich, Tobias\|Lubenau, Heinz\|Springer, Marco\|Breiner, Klaus M\|Mikus, Gerd\|Weitz, Jurgen\|Ulrich, Alexis\|Buechler, Markus W\|Pianka, Frank\|Klaiber, Ulla\|Diener, Markus\|Leowardi, Chris
PMID:	26137397

78.
Journal:	Medicine (Baltimore). 2015 Aug;94(32):e1303.
Title:	An Attempt to Evaluate Selected Aspects of "Bone-Fat Axis" Function in Healthy Individuals and Patients With Pancreatic Cancer.
Author:	Blogowski, Wojciech\|Dolegowska, Katarzyna\|Deskur, Anna\|Dolegowska, Barbara\|Starzynska, Teresa
PMID:	26266370

79.
Journal:	Clin Exp Metastasis. 2015 Dec;32(8):799-817.
Title:	Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors.
Author:	Moen, Ingrid\|Gebre, Matthew\|Alonso-Camino, Vanesa\|Chen, Debbie\|Epstein, David\|McDonald, Donald M
PMID:	26445848

80.
Journal:	Transl Oncogenomics. 2015 Nov 23;7(Suppl 1):13-31.
Title:	c-Met as a Target for Personalized Therapy.
Author:	Garajova, Ingrid\|Giovannetti, Elisa\|Biasco, Guido\|Peters, Godefridus J
PMID:	26628860

81.
Journal:	Rom J Intern Med. 2015 Jul-Sep;53(3):199-208.
Title:	VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.
Author:	Costache, M I\|Ioana, Mihai\|Iordache, Sevastita\|Ene, D\|Costache, Cornelia Alexandra\|Saftoiu, A
PMID:	26710495

82.
Journal:	Anticancer Agents Med Chem. 2016;16(6):771-80.
Title:	Multiple Pharmacological Properties of a Novel Parthenin Analog P16 as Evident by its Cytostatic and Antiangiogenic Potential Against Pancreatic Adenocarcinoma PANC -1 Cells.
Author:	Goswami, Akshra\|Shah, Bhahwal Ali\|Batra, Navneet\|Kumar, Ajay\|Guru, Santosh Kumar\|Bhushan, Shashi\|Malik, Fayaz Ahmad\|Joshi, Amit\|Singh, Jagtar
PMID:	26299660

83.
Journal:	Acta Biochim Biophys Sin (Shanghai). 2016 Jan;48(1):27-38.
Title:	RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies.
Author:	Fang, Bingliang
PMID:	26350096

84.
Journal:	Gastroenterology. 2016 Feb;150(2):513-25.e10.
Title:	Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.
Author:	Matzke-Ogi, Alexandra\|Jannasch, Katharina\|Shatirishvili, Marine\|Fuchs, Beatrix\|Chiblak, Sara\|Morton, Jennifer\|Tawk, Bouchra\|Lindner, Thomas\|Sansom, Owen\|Alves, Frauke\|Warth, Arne\|Schwager, Christian\|Mier, Walter\|Kleeff, Jorg\|Ponta, Helmut\|Abdollahi, Amir\|
PMID:	26597578

85.
Journal:	Eur J Med Chem. 2016 Apr 13;112:20-32.
Title:	The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity.
Author:	Newton, Rebecca\|Bowler, Katherine A\|Burns, Emily M\|Chapman, Philip J\|Fairweather, Emma E\|Fritzl, Samantha J R\|Goldberg, Kristin M\|Hamilton, Niall M\|Holt, Sarah V\|Hopkins, Gemma V\|Jones, Stuart D\|Jordan, Allan M\|Lyons, Amanda J\|Nikki March, H\|McDonald, Nei
PMID:	26874741

86.
Journal:	Oncotarget. 2016 Apr 19;7(16):21775-85.
Title:	DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis.
Author:	Choi, Hyeong Sim\|Lee, Kangwook\|Kim, Min Kyoung\|Lee, Kang Min\|Shin, Yong Cheol\|Cho, Sung-Gook\|Ko, Seong-Gyu
PMID:	26967562

87.
Journal:	Oncotarget. 2016 May 31;7(22):32969-79.
Title:	SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2.
Author:	Choi, Hyeong Sim\|Kim, Min Kyoung\|Lee, Kangwook\|Lee, Kang Min\|Choi, Youn Kyung\|Shin, Yong Cheol\|Cho, Sung-Gook\|Ko, Seong-Gyu
PMID:	27105528

88.
Journal:	Oncotarget. 2016 Jul 26;7(30):48265-48279.
Title:	The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.
Author:	Martinez-Bosch, Neus\|Guerrero, Pedro Enrique\|Moreno, Mireia\|Jose, Anabel\|Iglesias, Mar\|Munne-Collado, Jessica\|Anta, Hector\|Gibert, Joan\|Orozco, Carlos Alberto\|Vinaixa, Judith\|Fillat, Cristina\|Vinals, Francesc\|Navarro, Pilar
PMID:	27374084

89.
Journal:	Anticancer Res. 2016 Oct;36(10):5025-5030.
Title:	Antiangiogenic Therapy in Pancreatic Neuroendocrine Tumors.
Author:	Capozzi, Monica\|VON Arx, Claudia\|DE Divitiis, Chiara\|Ottaiano, Alessandro\|Tatangelo, Fabiana\|Romano, Giovanni Maria\|Tafuto, Salvatore
PMID:	27798861

90.
Journal:	Cancer Sci. 2017 Jan;108(1):73-80.
Title:	Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
Author:	Suzuki, Nobuaki\|Hazama, Shoichi\|Iguchi, Haruo\|Uesugi, Kazuhiro\|Tanaka, Hiroaki\|Hirakawa, Kosei\|Aruga, Atsushi\|Hatori, Takashi\|Ishizaki, Hidenobu\|Umeda, Yuzo\|Fujiwara, Toshiyoshi\|Ikemoto, Tetsuya\|Shimada, Mitsuo\|Yoshimatsu, Kazuhiko\|Shimizu, Ryoichi\|Hayash
PMID:	27783849

91.
Journal:	Int J Cancer. 2017 Feb 15;140(4):973-982.
Title:	Phase II clinical trial using novel peptide cocktail vaccine as a postoperative adjuvant treatment for surgically resected pancreatic cancer patients.
Author:	Miyazawa, Motoki\|Katsuda, Masahiro\|Maguchi, Hiroyuki\|Katanuma, Akio\|Ishii, Hiroshi\|Ozaka, Masato\|Yamao, Kenji\|Imaoka, Hiroshi\|Kawai, Manabu\|Hirono, Seiko\|Okada, Ken-Ichi\|Yamaue, Hiroki
PMID:	27861852

92.
Journal:	J Control Release. 2017 Jan 10;245:1-14.
Title:	Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation.
Author:	Huang, Jianfei\|Mei, Haijun\|Tang, Zhiyuan\|Li, Jieying\|Zhang, Xiaojing\|Lu, Yixiang\|Huang, Fang\|Jin, Qin\|Wang, Zhiwei
PMID:	27889393

93.
Journal:	Int J Mol Sci. 2017 Feb 17;18(2). pii: ijms18020439.
Title:	Determination of VEGFR-2 (KDR) 604A>G Polymorphism in Pancreatic Disorders.
Author:	Padureanu, Vlad\|Boldeanu, Mihail Virgil\|Streata, Ioana\|Cucu, Mihai Gabriel\|Silosi, Isabela\|Boldeanu, Lidia\|Bogdan, Maria\|Enescu, Anca Stefania\|Fortofoiu, Maria\|Enescu, Aurelia\|Dumitrescu, Elena Madalina\|Alexandru, Dragos\|Surlin, Valeriu Marian\|Fortofoiu,
PMID:	28218664

94.
Journal:	Expert Opin Emerg Drugs. 2017 Mar;22(1):77-86.
Title:	Emerging protein kinase inhibitors for treating pancreatic cancer.
Author:	Furuse, Junji\|Nagashima, Fumio
PMID:	28253828

95.
Journal:	Expert Opin Emerg Drugs. 2017 Mar;22(1):39-51.
Title:	Emerging antibodies for the treatment of pancreatic cancer.
Author:	Andrikou, Kalliopi\|Peterle, Chiara\|Pipitone, Stefania\|Salati, Massimiliano\|Cascinu, Stefano
PMID:	28253833

96.
Journal:	Lancet Oncol. 2017 Apr;18(4):486-499.
Title:	Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.
Author:	Middleton, Gary\|Palmer, Daniel H\|Greenhalf, William\|Ghaneh, Paula\|Jackson, Richard\|Cox, Trevor\|Evans, Anthony\|Shaw, Victoria E\|Wadsley, Jonathan\|Valle, Juan W\|Propper, David\|Wasan, Harpreet\|Falk, Stephen\|Cunningham, David\|Coxon, Fareeda\|Ross, Paul\|Madhusu
PMID:	28259610

97.
Journal:	Pathol Res Pract. 2017 Jun;213(6):639-642.
Title:	CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Author:	Cortes-Guiral, D\|Pastor-Iodate, C\|Diaz Del Arco, C\|Del Puerto-Nevado, L\|Fernandez-Acenero, M J
PMID:	28551384

98.
Journal:	Naunyn Schmiedebergs Arch Pharmacol. 2017 Nov;390(11):1125-1134.
Title:	A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo.
Author:	Mayer, Barbara\|Karakhanova, Svetlana\|Bauer, Nathalie\|Liu, Li\|Zhu, Yifan\|Philippov, Pavel P\|Werner, Jens\|Bazhin, Alexandr V
PMID:	28779210

99.
Journal:	Nat Commun. 2017 Sep 15;8(1):552.
Title:	Identification of the S100 fused-type protein hornerin as a regulator of tumor vascularity.
Author:	Gutknecht, Michael F\|Seaman, Marc E\|Ning, Bo\|Cornejo, Daniel Auger\|Mugler, Emily\|Antkowiak, Patrick F\|Moskaluk, Christopher A\|Hu, Song\|Epstein, Frederick H\|Kelly, Kimberly A
PMID:	28916756

100.
Journal:	Cell Death Dis. 2018 Feb 12;9(2):210.
Title:	Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells.
Author:	Nath, Shalini\|Mandal, Chhabinath\|Chatterjee, Uttara\|Mandal, Chitra
PMID:	29434218

101.
Journal:	Oncoimmunology. 2018 Jan 16;7(4):e1303584.
Title:	A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
Author:	Schmitz-Winnenthal, Friedrich H\|Hohmann, Nicolas\|Schmidt, Thomas\|Podola, Lilli\|Friedrich, Tobias\|Lubenau, Heinz\|Springer, Marco\|Wieckowski, Sebastien\|Breiner, Klaus M\|Mikus, Gerd\|Buchler, Markus W\|Keller, Anne-Valerie\|Koc, Ruhan\|Springfeld, Christoph\|Kneb
PMID:	29632710

102.
Journal:	Oncotarget. 2018 Apr 20;9(30):21613-21627.
Title:	Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review.
Author:	Sheahan, Anjali V\|Biankin, Andrew V\|Parish, Christopher R\|Khachigian, Levon M
PMID:	29765563

103.
Journal:	Onco Targets Ther. 2018 May 9;11:2685-2698.
Title:	Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis.
Author:	Wu, Jun\|Wang, Jing\|Su, Qiang\|Ding, Wei\|Li, Teng\|Yu, Junxian\|Cao, Bangwei
PMID:	29785118

104.
Journal:	J Pathol. 2018 Jul 20.
Title:	VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
Author:	Morin, Eric\|Sjoberg, Elin\|Tjomsland, Vegard\|Testini, Chiara\|Lindskog, Cecilia\|Franklin, Oskar\|Sund, Malin\|Ohlund, Daniel\|Kiflemariam, Sara\|Sjoblom, Tobias\|Claesson-Welsh, Lena
PMID:	30027561

105.
Journal:	Oncol Rep. 2018 Nov;40(5):3102-3111.
Title:	Tanshinone IIA can inhibit MiaPaCa2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.
Author:	Su, Chin-Cheng
PMID:	30226540